Among the 20 patients with mitral valve prolapse, 13 (65%) had PKD1 truncating mutations, 5 (25%) had PKD1 non-truncating mutations and 2 (10%) had PKD2 mutations (Table 3). This evidence concerns the gene PKD1 and mitral valve disorder.